PATRICIA CHAMUL: Open Payments
NPI 1619287869 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 8 payments from 7 companies in 2025. Trend: 2023 $265 · 2024 $317 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 1 | $34 |
| ABIOMED | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: MOUNJARO, KRYSTEXXA, SHINGRIX, ROTATEQ, Ozempic.
Industry payments across CA — which companies pay providers there.
